Xtant Medical Holdings Inc

Research Xtant Medical Holdings Inc (XTNT) on Bullrun: market cap USD 44.88M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 44.88M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 133.93MUSD 4.97MUSD 10.16M62.9%0.03USD 17.05MUSD 14.53MUSD 50.95M
FY2024USD 117.27M-USD 16.45M-USD 16.01M58.2%-0.12USD 6.20MUSD 22.04MUSD 42.96M
FY2023USD 91.30MUSD 660.00K-USD 10.97M60.8%0.01USD 5.72MUSD 17.17MUSD 51.35M
FY2022USD 57.97M-USD 8.49M-USD 7.11M55.4%-0.09USD 20.30MUSD 12.02MUSD 34.17M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-25USD 44.88Mn/an/an/a
20252025-12-31USD 109.23M26.0n/an/a
20242024-12-31USD 61.18Mn/an/an/a
20232023-12-29USD 147.02M113.0n/an/a
20222022-12-30USD 71.72Mn/an/an/a
20212021-12-31USD 48.76Mn/an/an/a

About Xtant Medical Holdings Inc

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization;

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Xtant Medical Holdings Inc's market cap?

Xtant Medical Holdings Inc's market capitalization is USD 44.88M.

What does Xtant Medical Holdings Inc do?

Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally.